Bifogade filer
PDF
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Medicover AB (publ) ("Medicover (http://www.medicover.com)") publishes the nomination committee's composition for the annual general meeting in 2024.
- Fredrik Stenmo, representing Celox Holding AB and the Christina af Jochnick family's total shareholding
- Hans Ramel, NG Invest Beta AB
- Jannis Kitsakis, Fjärde AP-Fonden
- Angelica Hanson, AMF och AMF Fonder
The Board of Medicover AB (publ)
For more information, please visit:medicover.com (https://www.medicover.com/financial-information/corporate-governance/nomination-committee)
Shareholders who wish to submit proposals to the nomination committee for the annual general meeting to be held on 26 April 2024 can do so by e-mail to nominationcommittee@medicover.comor:
Medicover AB
Att: Nomination Committee/General Legal Counsel
Box 5283, 102 46 Stockholm
Sweden
Proposals should be submitted to the nomination committee at latest on 8 March 2024.
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
hanna.bjellquist@medicover.com
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2022, Medicover had revenue of €1,510 million and more than 44,700 employees. For more information, go to www.medicover.com